Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |